Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (19504)	4/23/1998 7:54:00 PM
From: Hippieslayer	Read Replies (1) \| Respond to of 32384

A question. Those who r infected with HIV, I would assume, are quickly put on the cocktail of prot. Inhibs. I don't know the percentages, but if those who go on these drugs are able to delay or stop the onset of AIDS related diseases (eg KS), doesn't lgnd have a problem in that their disease bases is shrinking before their eyes? KS in older people(non hiv) is evident but they still represent a small number. What is lgnd's projection of sales of P-gel if approved?